Literature DB >> 11818451

The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts.

Kim C Mansky1, Kavita Marfatia, Georgia H Purdom, Alex Luchin, David A Hume, Michael C Ostrowski.   

Abstract

The microphthalmia transcription factor (MITF) regulates gene expression during differentiation of several distinct cell types, including osteoclasts. A structure/function analysis was performed to determine whether transcription activation domains were important for MITF action in osteoclasts. In addition to a previously characterized acidic activation necessary for melanocyte differentiation, the analysis defined a second potential activation domain located between amino acids 140 and 185. This second domain is required for MITF transactivation of two probable targets, the E-cadherin promoter and the tartrate-resistant acid phosphatase promoter, in transient transfection assays. An intact MITF gene rescued differentiation when introduced into osteoclasts derived from mi/mi mice using a retrovirus vector. In parallel experiments, an MITF gene lacking the acidic-activation domain rescued differentiation twofold less efficiently than wild type, and a gene lacking the region between amino acid residues 140 and 185 rescued differentiation tenfold less efficiently than wild type. The results indicate that the N-terminal region of MITF is necessary for activation of gene expression in osteoclasts and provides one mechanism by which this factor regulates distinct target genes in different cell types.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818451

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  6 in total

1.  A novel isoform of microphthalmia-associated transcription factor inhibits IL-8 gene expression in human cervical stromal cells.

Authors:  Xiang-Hong Li; A Hari Kishore; Doan Dao; Weiming Zheng; Christopher A Roman; R Ann Word
Journal:  Mol Endocrinol       Date:  2010-06-23

2.  HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.

Authors:  Lan Pham; Bria Kaiser; Amanda Romsa; Toni Schwarz; Raj Gopalakrishnan; Eric D Jensen; Kim C Mansky
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

3.  Downregulation of Gnas, Got2 and Snord32a following tenofovir exposure of primary osteoclasts.

Authors:  Iwen F Grigsby; Lan Pham; Raj Gopalakrishnan; Louis M Mansky; Kim C Mansky
Journal:  Biochem Biophys Res Commun       Date:  2009-12-21       Impact factor: 3.575

Review 4.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

5.  Eos, MITF, and PU.1 recruit corepressors to osteoclast-specific genes in committed myeloid progenitors.

Authors:  Rong Hu; Sudarshana M Sharma; Agnieszka Bronisz; Ruchika Srinivasan; Uma Sankar; Michael C Ostrowski
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

Review 6.  Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.

Authors:  Kristina M Ilieva; Anthony Cheung; Silvia Mele; Giulia Chiaruttini; Silvia Crescioli; Merope Griffin; Mano Nakamura; James F Spicer; Sophia Tsoka; Katie E Lacy; Andrew N J Tutt; Sophia N Karagiannis
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.